ClinicalTrials.gg
Sign In
Status unknownNCT04693065Updated Jan 5, 2021

Pronostic Factors of Long Term Outcome in Patients With Clubfoot Treated by the Ponseti Method

An observational study in Clubfoot, sponsored by Hospices Civils de Lyon. Status unknown at 1 site in France. Open to participants aged 3 Months and older. Per ClinicalTrials.gov, last updated 2021-01-05.

Sponsored by Hospices Civils de Lyon · Observational

The sponsor has not verified this record recently (last verified Sep 2020), so the status shown — last known as Active, not recruiting — may be out of date.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
100
Ages
3 Months and older
Sex
All
01

Study summary

We aim at finding prognostic factors of long term (after growth) function outcome in patient with clubfoot treated by ponseti method, based on a very complete prospective recording of treatment variables and outcome

02

Conditions studied

  • Clubfoot

Browse trials for

03

In context

Clubfoot

69 studies on the registry are indexed under Clubfoot; 15 are open to participants now.

This study's enrollment of 100 is above the median of 55 across 27 observational studies indexed under Clubfoot.

Browse Clubfoot studies →

Lead sponsor

Hospices Civils de Lyon is the lead sponsor of 1,867 studies on the registry; 448 are open to participants now.

Browse Hospices Civils de Lyon studies →

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
3 Months and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients treated by ponseti method

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

    • Patients treated by ponseti method for clubfoot-

Exclusion criteria

Exclusion Criteria:

    • other malformation associated / congenital
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
100 participants (actual)
Patient registry
No

Groups and cohorts

  • Ponseti

    Patients treated by ponseti method

    Other: ponseti

Interventions

  • Otherponseti

    Standard of care, treatment by ponseti method

06

What researchers measure

Primary outcomes

  1. Function at >16 years

    Composite score (perfect or non-perfect function), perfect foot defined as a plantigrade, non painful, valgus barefoot with \>10° dorsal flexion. Non-perfect otherwise.

    Time frame: at 18 years old or complete bone maturity

07

Study locations

1 site
  • Hopital femme mere enfants
    Lyon, France
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Jan 2020 (actual). Primary completion is estimated for Jan 2021, 12 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 18, 2020
First posted
Jan 5, 2021
StartActual
Jan 1, 2020
Primary completionEst.
Jan 1, 2021
CompletionEst.
Jun 1, 2021
Last update
Jan 5, 2021
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jan 5, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT04693065
Lead sponsor
Hospices Civils de Lyon
Responsible party
Sponsor
First posted
Jan 5, 2021
Start date
Jan 1, 2020
Primary completion
Jan 1, 2021 (estimated)
Completion
Jun 1, 2021 (estimated)
Last update
Jan 5, 2021

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Sep 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies in this condition

Clubfoot →

Other studies from this sponsor

Hospices Civils de Lyon →

Start the discussion